ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 278 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q2 2022. The put-call ratio across all filers is 0.90 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $75,209 | -31.5% | 2,799 | -9.0% | 0.05% | -29.2% |
| Q2 2023 | $109,726 | +40.3% | 3,077 | -0.0% | 0.06% | +51.2% |
| Q1 2023 | $78,181 | -54.8% | 3,078 | -27.8% | 0.04% | -52.2% |
| Q4 2022 | $172,948 | +39.5% | 4,264 | +13.9% | 0.09% | +83.7% |
| Q3 2022 | $124,000 | -5.3% | 3,742 | +0.6% | 0.05% | 0.0% |
| Q2 2022 | $131,000 | +26.0% | 3,718 | +64.7% | 0.05% | +4.3% |
| Q1 2022 | $104,000 | -34.6% | 2,258 | -5.9% | 0.05% | -21.7% |
| Q4 2021 | $159,000 | +6.0% | 2,400 | -0.1% | 0.06% | -9.1% |
| Q3 2021 | $150,000 | -28.6% | 2,403 | -5.0% | 0.07% | -23.3% |
| Q2 2021 | $210,000 | -21.1% | 2,530 | -36.8% | 0.09% | -23.2% |
| Q1 2021 | $266,000 | -11.9% | 4,006 | +1.7% | 0.11% | -10.4% |
| Q4 2020 | $302,000 | -25.6% | 3,938 | -58.2% | 0.12% | -41.3% |
| Q3 2020 | $406,000 | -12.1% | 9,424 | -12.0% | 0.21% | -2.7% |
| Q2 2020 | $462,000 | +198.1% | 10,705 | +98.2% | 0.22% | +242.2% |
| Q1 2020 | $155,000 | -60.6% | 5,401 | -12.8% | 0.06% | 0.0% |
| Q4 2019 | $393,000 | +42.4% | 6,196 | -36.7% | 0.06% | +14.3% |
| Q3 2019 | $276,000 | +0.7% | 9,785 | -5.3% | 0.06% | -3.4% |
| Q2 2019 | $274,000 | -17.7% | 10,330 | -43.0% | 0.06% | -91.8% |
| Q1 2019 | $333,000 | +32.1% | 18,120 | -10.6% | 0.71% | +1548.8% |
| Q4 2018 | $252,000 | -66.8% | 20,261 | -48.8% | 0.04% | -44.9% |
| Q3 2018 | $758,000 | -18.8% | 39,546 | -42.3% | 0.08% | -90.5% |
| Q2 2018 | $933,000 | +193.4% | 68,587 | +58.5% | 0.82% | +435.7% |
| Q3 2016 | $318,000 | +38.3% | 43,272 | 0.0% | 0.15% | -9.9% |
| Q2 2016 | $230,000 | – | 43,272 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,264 | $54,392,000 | 33.22% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $216,228,000 | 28.00% |
| L1 Capital Pty Ltd | 296,024 | $19,629,000 | 4.93% |
| Aquilo Capital Management, LLC | 407,926 | $27,050,000 | 4.89% |
| Evolutionary Tree Capital Management, LLC | 72,948 | $4,837,000 | 2.86% |
| ACUTA CAPITAL PARTNERS, LLC | 108,000 | $7,161,000 | 2.58% |
| First Light Asset Management, LLC | 536,836 | $35,598,000 | 2.36% |
| Parkman Healthcare Partners LLC | 70,089 | $4,648,000 | 1.08% |
| Hood River Capital Management LLC | 357,082 | $23,678,000 | 0.76% |
| Vanguard Capital Wealth Advisors | 11,099 | $703,565,000 | 0.60% |